BCKDHA-BCKDHB digenic gene therapy restores metabolic homeostasis in two mouse models and a calf with classic maple syrup urine disease.
Wang J, Poskitt LE, Gallagher J, Puffenberger EG, Wynn RM, Shishodia G, Chuang DT, Beever J, Hardin DL, Brigatti KW, Baker WC, Gately R, Bertrand S, Rodrigues A, Benatti HR, Taghian T, Hall E, Prestigiacomo R, Liang J, Chen G, Zhou X, Ren L, Liu N, He R, Su Q, Xie J, Jiang Z, Gruntman A, Gray-Edwards H, Gao G, Strauss KA, Wang D.
Wang J, et al.
Sci Transl Med. 2025 Feb 26;17(787):eads0539. doi: 10.1126/scitranslmed.ads0539. Epub 2025 Feb 26.
Sci Transl Med. 2025.
PMID: 40009698
Classic maple syrup urine disease (MSUD) results from biallelic mutations in genes that encode the branched-chain alpha-ketoacid dehydrogenase E1alpha (BCKDHA), E1beta (BCKDHB), or dihydrolipoamide branched-chain transacylase (DBT) subuni …
Classic maple syrup urine disease (MSUD) results from biallelic mutations in genes that encode the branched-chain alpha-ketoac …